Expert Debate: The Ethics of Consumer Genetic Testing

Be part of the knowledge.

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Expert Debate: The Ethics of Consumer Genetic Testing

Is consumer access to genetic testing, without a doctor's involvement, beneficial or harmful for patients? This debate examines both sides.
  • Overview

    For the first time, the FDA has approved a direct-to-consumer genetic test from 23andme that will inform patients if they are predisposed to diseases such as Parkinson’s, Alzheimer's, and Celiac Disease among others.

    Proponents applaud this decision, saying this will allow for people to know their genetic health risks and be more proactive about their health. Others argue that this information doesn’t tell the whole story since predisposition doesn't reflect someone's ultimate risk or likelihood of developing a disease. What are the benefits and liabilities of consumers' access to genetic testing?

    Host Dr. David Weisman, Director of Clinical Trials at Abington Neurological Associates, sits down with Dr. John Khoury, Associate Director at Abington Memorial Hospital Sleep Disorders Center, to debate the merits and pitfalls of direct-to-consumer genetic testing.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio



    You must be in to display playlists.

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.